Simplex Trading’s Odonate Therapeutics, Inc. Common Stock ODT Stock Holding History

Simplex Trading’s Portfolio ODT Stock Details ODT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-13,100	Closed	-$19K	–	11966
2021 Q4	$19K	Sell	13,100 -13,700	-51%	-$32.4K	﹤0.01%	8448
2021 Q3	$90K	Hold	26,800	–	–	﹤0.01%	6775
2021 Q2	$93K	Buy	26,800 +26,099	+3,723%	+$89.6K	﹤0.01%	6845
2021 Q1	$239K	Buy	701 +687	+4,907%	+$13K	﹤0.01%	4480
2020 Q4	$26K	Sell	14 -43	-75%	-$664	﹤0.01%	6804
2020 Q3	$76K	Buy	+57	New	+$1.62K	﹤0.01%	5202

Simplex Trading's ODT Position: Q2 2022 in Review

Simplex Trading sold out of Odonate Therapeutics, Inc. Common Stock (ODT) in Q2 2022, closing a stake of 2,000 shares — an estimated $2K sold.

Simplex Trading first reported a position in ODT in Q2 2020 and held it in 7 quarters. The position peaked at $202K in Q1 2021. 0 funds tracked by Wall St. Rank hold ODT as of Q2 2022.

Simplex Trading reported no remaining Odonate Therapeutics, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Simplex Trading sold 2,000 Odonate Therapeutics, Inc. Common Stock shares in Q2 2022, an estimated $2K.
Simplex Trading first reported a position in Odonate Therapeutics, Inc. Common Stock in Q2 2020 and held it in 7 quarters.
Simplex Trading's Odonate Therapeutics, Inc. Common Stock position peaked at $202K in Q1 2021.
0 funds tracked by Wall St. Rank held Odonate Therapeutics, Inc. Common Stock as of Q2 2022.

Based on Simplex Trading's 13F filing for Q2 2022, filed 3 Aug 2022.